Physician Wealth Advisors Inc. Sells 14,296 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Physician Wealth Advisors Inc. trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 21.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 53,549 shares of the company’s stock after selling 14,296 shares during the quarter. HealthEquity accounts for approximately 0.9% of Physician Wealth Advisors Inc.’s holdings, making the stock its 28th largest position. Physician Wealth Advisors Inc. owned approximately 0.06% of HealthEquity worth $5,138,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new position in HealthEquity during the 4th quarter worth $26,000. Smartleaf Asset Management LLC boosted its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares during the last quarter. UMB Bank n.a. boosted its holdings in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after purchasing an additional 164 shares during the last quarter. Skandinaviska Enskilda Banken AB publ increased its holdings in HealthEquity by 1,934.8% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock valued at $45,000 after purchasing an additional 445 shares during the last quarter. Finally, Lindbrook Capital LLC grew its holdings in shares of HealthEquity by 27.6% in the fourth quarter. Lindbrook Capital LLC now owns 750 shares of the company’s stock valued at $72,000 after purchasing an additional 162 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HQY has been the subject of a number of recent research reports. Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 target price for the company. The Goldman Sachs Group decreased their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a research report on Thursday. Royal Bank of Canada raised their price target on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. KeyCorp reduced their price objective on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday, March 24th. Finally, Wells Fargo & Company boosted their price target on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $112.23.

HealthEquity Stock Down 2.1 %

HQY stock opened at $86.96 on Friday. The company’s 50 day simple moving average is $103.63 and its 200-day simple moving average is $96.06. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a market capitalization of $7.52 billion, a P/E ratio of 79.78, a P/E/G ratio of 1.60 and a beta of 0.62.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.